Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL11443708 | 1.00 | CA5A (0.86) | — | |
| Sulfuric Acid SCHEMBL10744664 | 1.00 | CA5A (0.86) | — | |
| Sulfuric Acid SCHEMBL31464825 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL11574785 | 1.00 | CA5A (0.86) | — | |
| Sulfuric Acid SCHEMBL4691724 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL7259315 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL5181329 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL2670358 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL4533743 | 0.94 | — | — | |
| Sulfuric Acid SCHEMBL2542517 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4376957-A1 | ANTI-MICROBIAL SULFONAMIDE PHARMACEUTICAL COMPOSITIONS FOR EXTERNAL USE | Rem Brands, Inc. (US) | 2024-06-05 | — | — | EP | disclosed |
| EP-4376956-A1 | HALO ACTIVE AROMATIC SULFONAMIDE PHARMACEUTICAL COMPOSITIONS FOR INTERNAL USE | Rem Brands, Inc. (US) | 2024-06-05 | — | — | EP | disclosed |
| EP-3189841-B1 | PHARMACEUTICAL PREPARATION COMPRISING CEPHALOSPORIN HAVING CATECHOL GROUPS | SHIONOGI & CO (JP) | 2023-11-22 | — | — | EP | disclosed |
| US-20230225976-A1 | LYOPHILIZED FORMULATION CONTAINING CEPHALOSPORIN HAVING CATECHOL GROUP AND THE MANUFACTURING METHOD | SHIONOGI & CO., LTD. (JP) | 2023-07-20 | — | — | US | disclosed |
| US-20230200387-A9 | HALO ACTIVE AROMATIC SULFONAMIDE ANTIMICROBIAL COMPOSITIONS | Rem Brands, Inc. | 2023-06-29 | — | — | US | disclosed |
| EP-4195927-A1 | HALO ACTIVE AROMATIC SULFONAMIDE ANTIMICROBIAL AND ODOR CONTROL COATINGS | Rem Brands, Inc. (US) | 2023-06-21 | — | — | EP | disclosed |
| US-20230052601-A1 | HALO ACTIVE AROMATIC SULFONAMIDE PHARMACEUTICAL COMPOSITIONS FOR INTERNAL USE | Rem Brands Inc. | 2023-02-16 | — | — | US | disclosed |
| US-20230030847-A1 | ANTI-MICROBIAL SULFONAMIDE PHARMACEUTICAL COMPOSITIONS FOR EXTERNAL USE | Rem Brands Inc. | 2023-02-02 | — | — | US | disclosed |
| WO-2023009798-A1 | HALO ACTIVE AROMATIC SULFONAMIDE PHARMACEUTICAL COMPOSITIONS FOR INTERNAL USE | Rem Brands, Inc. (US) | 2023-02-02 | — | — | WO | disclosed |
| WO-2023009824-A1 | ANTI-MICROBIAL SULFONAMIDE PHARMACEUTICAL COMPOSITIONS FOR EXTERNAL USE | Rem Brands, Inc. (US) | 2023-02-02 | — | — | WO | disclosed |
| US-20220401326-A1 | DEODORANT AND PERSONAL CARE COMPOSITIONS | Rem Brands Inc. | 2022-12-22 | — | — | US | disclosed |
| EP-4084774-A1 | DEODORANT AND PERSONAL CARE COMPOSITIONS | Rem Brands, Inc. (US) | 2022-11-09 | — | — | EP | disclosed |
| US-11439574-B2 | Deodorant and personal care compositions | Rem Brands, Inc. (US) | 2022-09-13 | — | — | US | disclosed |
| EP-3256088-B1 | ARTICLES WITH ODOR-CONTROLLING COMPOSITION | REM BRANDS INC (US) | 2022-09-07 | — | — | EP | disclosed |
| WO-2022025091-A1 | LYOPHILIZED FORMULATION CONTAINING CEPHALOSPORIN HAVING CATECHOL GROUP, AND METHOD FOR PRODUCING SAME | 塩野義製薬株式会社 | 2022-02-03 | — | — | WO | disclosed |